Traws Pharma Files 8-K for Material Agreement
Ticker: TRAW · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Traws Pharma (fka Onconova) signed a big deal, filing an 8-K on 3/10/25.
AI Summary
Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed an 8-K on March 10, 2025, reporting the entry into a material definitive agreement and the filing of financial statements and exhibits. The company is incorporated in Delaware and its principal business address is in Newtown, PA.
Why It Matters
This filing indicates Traws Pharma has entered into a significant agreement, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — An 8-K filing regarding a material definitive agreement can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- March 10, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Newtown, PA (location) — Business address
FAQ
What is the nature of the material definitive agreement entered into by Traws Pharma, Inc.?
The filing states that Traws Pharma, Inc. entered into a material definitive agreement, but the specific details of this agreement are not provided in the excerpt.
When was this 8-K filing submitted?
The 8-K filing was submitted on March 10, 2025.
What was Traws Pharma, Inc. previously known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
Where is Traws Pharma, Inc. located?
Traws Pharma, Inc.'s business address is 12 Penns Trail, Newtown, PA 18940.
What is the SIC code for Traws Pharma, Inc.?
The Standard Industrial Classification (SIC) code for Traws Pharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Traws Pharma, Inc. (TRAW).